Regorafenib promotes antitumor progression in melanoma by reducing RRM2

Xiuyun Xuan(Union Hospital), Yong Zhang(First Affiliated Hospital of Bengbu Medical College)
iScience
September 19, 2024
Cited by 4


Related Papers